OBJECTIVES

We aim to establish continuous and long term growth by +15 - 25 % annually by:

• acquiring a minimum of 1 proprietory product per year.
• focusing on specific therapeutic areas such as Oncology and Infectious Disease.

We aim to generate profitability above industry average.